Please use this identifier to cite or link to this item: https://scholarbank.nus.edu.sg/handle/10635/36446
DC FieldValue
dc.titleCHARACTERISATION OF DRUG INDUCED CELL DEATH IN MYCOBACTERIUM SMEGMATIS
dc.contributor.authorVARSHA SRIVATSAN
dc.date.accessioned2013-03-13T18:00:14Z
dc.date.available2013-03-13T18:00:14Z
dc.date.issued2012-12-27
dc.identifier.citationVARSHA SRIVATSAN (2012-12-27). CHARACTERISATION OF DRUG INDUCED CELL DEATH IN MYCOBACTERIUM SMEGMATIS. ScholarBank@NUS Repository.
dc.identifier.urihttp://scholarbank.nus.edu.sg/handle/10635/36446
dc.description.abstractThe study on Gram- positive and Gram-negative bacteria by Kohanksi et al. (2007) challenged the longstanding notion about antibiotic induced cell death. The authors showed that these bacteria illustrate a common death pathway when exposed to fluoroquinolones, aminoglycosides and ß-lactams. Cell death, they show, is caused by the production of hydroxyl radicals via the fenton reaction. To determine whether the same pathway is triggered in the evolutionary distinct Mycobacteria, studies were conducted with the fast growing workhorse model organism, M.smegmatis. Upon adapting the protocol described in Kohanski (2008), it was found that we could measure hydroxyl radicals in M. smegmatis generated by H2O2. We show that fluoroquinolones produce hydroxyl radicals, and that the quenching of these radicals resulted in increased bacterial survival indicating their involvement in causing cell death. Three other drugs which are used in Tb therapy, isoniazid, kanamycin and ethambutol were also tested. However, none of them significantly induced hydroxyl radicals. These results suggest that, in contrast to other bacteria, mycobacteria harbor hydroxyl radical dependent as well as independent cell death pathways. This study serves as a foundation to further our knowledge about pathways triggering reactive oxygen species and how we could use them to identify new targets for drug discovery. If such a pathway is activated in M. tuberculosis, it might prove to be very useful in our fight against drug resistant tuberculosis.
dc.language.isoen
dc.subjectMycobacterium smegmatis, Hydroxyl radical, Antibiotics, Hydroxy Phenyl Fluorscein, Drug discovery, TB
dc.typeThesis
dc.contributor.departmentMICROBIOLOGY
dc.contributor.supervisorTHOMAS DICK
dc.description.degreeMaster's
dc.description.degreeconferredJOINT M.SC. IN INFECTIOUS DISEASES, VACCINOLOGY AND DRUG DISCOVERY
dc.identifier.isiutNOT_IN_WOS
Appears in Collections:Master's Theses (Open)

Show simple item record
Files in This Item:
File Description SizeFormatAccess SettingsVersion 
Srivatsan.V MSc.pdf1.21 MBAdobe PDF

OPEN

NoneView/Download

Google ScholarTM

Check


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.